Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,268.00
Bid: 11,222.00
Ask: 11,226.00
Change: 18.00 (0.16%)
Spread: 4.00 (0.036%)
Open: 11,250.00
High: 11,362.00
Low: 11,220.00
Prev. Close: 11,250.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) Replacement Astrazeneca Plc

21 May 2014 11:33

RNS Number : 6897H
Morgan Stanley Securities Limited
21 May 2014
 



 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ASTRAZENECA PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

20 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 USD 0.25 ORDINARY

 PURCHASES

 3,460,837

 43.0850 GBP

 41.8450 GBP

 USD 0.25 ORDINARY

 SALES

 4,967,994

 43.0850 GBP

 41.8650 GBP

 USD 0.25 ORDINARY

 PURCHASES

 463,592

 

 72.5175 GBP

 

 72.0775 GBP

 

 USD 0.25 ORDINARY

 SALES

 74,500

 

 72.2000 GBP

 

 72.2000 GBP

 

 ADRS

 PURCHASES

 513,092.00 (Traded in ADR form)

 72.5175 USD

 72.0775 USD

 ADRS

 SALES

 513,092.00 (Traded in ADR form)

 72.4700 USD

 72.2000 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 USD 0.25 ORDINARY

 CFD

 LONG

 145

 52.5544 EUR

 USD 0.25 ORDINARY

 CFD

 LONG

 168

 52.7800 EUR

 USD 0.25 ORDINARY

 CFD

 SHORT

 145

 52.3220 EUR

 USD 0.25 ORDINARY

 CFD

 SHORT

 168

 52.4100 EUR

 USD 0.25 ORDINARY

 CFD

 LONG

 100

 41.9550 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 2,302

 42.0239 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 62

 42.0239 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 2,302

 42.0273 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 87

 42.2113 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 274

 42.2113 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 497

 42.2250 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 109,000

 42.3010 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,216

 42.3237 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 7,505

 42.3237 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 8,433

 42.3237 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 928

 42.3237 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 520

 42.3826 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,729

 42.3826 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 2,365

 42.3826 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,209

 42.3826 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 166,059

 42.4116 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 105,750

 42.4190 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 122,500

 42.4794 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 227,500

 42.4794 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 7,412

 42.4806 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 200,000

 42.5265 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 774,196

 42.5860 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 11,157

 42.5985 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 19,840

 42.6477 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 856

 42.7261 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 5,361

 42.7404 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 2,385

 42.7404 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 11,004

 42.7404 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 162,500

 42.7516 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 87,500

 42.7516 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 98,000

 42.7911 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 182,000

 42.7911 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 200

 42.8000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 463

 42.8167 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 6,424

 42.8239 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 19,498

 42.8502 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 595

 42.8502 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 5,000

 42.8744 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 26,075

 42.9000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 48,425

 42.9000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 20

 42.9185 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 1,209

 42.9258 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 54

 42.9258 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 268

 42.9258 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 3,400

 42.9650 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 160

 43.0485 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 60

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 29,049

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,000

 41.9712 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 100

 42.0100 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 91

 42.0137 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,051

 42.0137 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 455

 42.0137 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 200

 42.0300 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 6,999

 42.0376 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 3,385

 42.0376 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 241

 42.0376 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 81

 42.0376 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 47

 42.0400 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 66,786

 42.0814 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 180

 42.1137 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 1,430

 42.2781 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 274

 42.2781 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4,386

 42.2781 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 19,840

 42.3194 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 473

 42.3500 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 106,750

 42.3548 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 166,059

 42.3688 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 6,600

 42.3850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 600

 42.3850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 301

 42.3950 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 323

 42.4000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,700

 42.4000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 122

 42.4494 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 149

 42.4650 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 160

 42.4900 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 132

 42.5000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 780,864

 42.5724 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4,404

 42.5724 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 5,331

 42.5814 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 8,418

 42.5814 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 14,311

 42.5814 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 1,242

 42.6778 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 507

 42.8105 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 19,498

 42.8105 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4,000

 42.8144 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 8,000

 42.8144 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 7,120

 42.8144 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 880

 42.8144 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,877

 42.8382 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4,638

 42.8382 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 1,424

 42.8382 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 1,594

 42.8382 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 3,567

 42.8382 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 35

 42.8525 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 1

 42.8800 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 173

 42.8864 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 928

 42.9105 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 8,433

 42.9105 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4,216

 42.9105 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 7,505

 42.9105 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 157

 42.9688 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 13,354

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 567

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 116

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 205

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 1,108

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 15,862

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,759

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 499

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 368

 43.0850 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 332

 43.0850 GBP

USD 0.25 ORDINARY

 FUTURE

 SALE

 21

 4,206.4870 GBP

 ADRS

 CFD

LONG

 3,402.00 (Traded in ADR form)

 71.3720 USD

 ADRS

 CFD

LONG

 2,440.00 (Traded in ADR form)

 72.0000 USD

 ADRS

 CFD

LONG

 401.00 (Traded in ADR form)

 72.0000 USD

 ADRS

 CFD

LONG

 400.00 (Traded in ADR form)

 72.3300 USD

 ADRS

 CFD

SHORT

 3,402.00 (Traded in ADR form)

 72.1411 USD

 ADRS

 CFD

SHORT

 400.00 (Traded in ADR form)

 72.2000 USD

 ADRS

 CFD

SHORT

 392.00 (Traded in ADR form)

 72.2000 USD

 ADRS

 CFD

SHORT

 2,386.00 (Traded in ADR form)

 72.2000 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 ADRS

 PUT

 PURCHASE

 700,000

 34.0000

 A

 19/12/2014

 0.4000 GBP

 USD 0.25 ORDINARY

 PUT

 PURCHASE

 13,000

 41.0000

 E

 19/12/2014

 2.6000 GBP

 USD 0.25 ORDINARY

 CALL

 SALE

 392,000

 52.0000

 A

 19/09/2014

 0.7100 GBP

 USD 0.25 ORDINARY

 CALL

 SALE

 200,000

52.0000

 A

 19/09/2014

 0.7250 GBP

 USD 0.25 ORDINARY

 CALL

 SALE

 108,000

52.0000

 A

 19/09/2014

 0.7250 GBP

 USD 0.25 ORDINARY

 CALL

 SALE

 13,000

 44.7300

 E

 19/12/2014

 2.6000 GBP

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

21 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERLLFVIEFILFIS
Date   Source Headline
11th Apr 20245:30 pmRNSResult of AGM
11th Apr 20247:00 amRNSAstraZeneca increases 2024 dividend by 7%
8th Apr 20247:00 amRNSEnhertu approved in US for HER2+ solid tumours
5th Apr 20247:00 amRNSImfinzi improved OS & PFS in limited-stage SCLC
2nd Apr 20243:00 pmRNSTotal Voting Rights
2nd Apr 20247:05 amRNSVoydeya approved in US
2nd Apr 20247:00 amRNSFDA accepts Dato-DXd BLA for breast cancer
25th Mar 20247:00 amRNSUltomiris approved in the US for NMOSD
19th Mar 20247:00 amRNSAstraZeneca to acquire Fusion
14th Mar 20247:00 amRNSAstraZeneca to acquire Amolyt
12th Mar 202411:00 amRNSDirector/PDMR Shareholding
7th Mar 202411:00 amRNSNotice of AGM
6th Mar 20243:05 pmRNSDirector/PDMR Shareholding
6th Mar 20243:00 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSEMA validates Dato-DXd MAAs for NSQ NSCLC and BC
1st Mar 20243:00 pmRNSTotal Voting Rights
26th Feb 20247:00 amRNSVoydeya recommended for EU approval
22nd Feb 20241:15 pmRNSAcquisition of Gracell completed
22nd Feb 202411:00 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSAstraZeneca prices a $5bn bond offering
21st Feb 20247:00 amRNSFiling of Form 20-F with SEC
20th Feb 202411:00 amRNSAnnual Financial Report
19th Feb 20243:00 pmRNSAstraZeneca completes acquisition of Icosavax
19th Feb 20247:10 amRNSTagrisso plus chemo approved in US for lung cancer
19th Feb 20247:05 amRNSFDA accepts Dato-DXd BLA for nonsquamous NSCLC
19th Feb 20247:00 amRNSTagrisso improved PFS in Stage III lung cancer
8th Feb 20247:00 amRNSFinal Results
1st Feb 20243:00 pmRNSTotal Voting Rights
2nd Jan 20243:00 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSAstraZeneca acquires Gracell
22nd Dec 20237:00 amRNSWainua (eplontersen) granted first US FDA approval
14th Dec 20233:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:05 amRNSAstraZeneca to acquire Icosavax
1st Dec 20233:05 pmRNSBlock listing Interim Review
1st Dec 20233:00 pmRNSTotal Voting Rights
1st Dec 20237:00 amRNSDiscontinuation of two CRYSTALIZE evidence trials
23rd Nov 20233:00 pmRNSDirector/PDMR Shareholding
17th Nov 20237:00 amRNSTruqap approved in US for HR+ breast cancer
14th Nov 20237:05 amRNSUpdate on PACIFIC-2 Phase III trial for Imfinzi
9th Nov 20233:00 pmRNSDirector Declaration
9th Nov 20237:10 amRNSImfinzi combination improves PFS in liver cancer
9th Nov 20237:05 amRNSAgreement with Eccogene for clinical stage GLP-1RA
9th Nov 20237:00 amRNS9M and Q3 2023 results
1st Nov 20233:00 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSAstraZeneca cell & gene therapy deal w/ Cellectis
3rd Oct 20237:00 amRNSAstraZeneca settles Nexium liability litigations
2nd Oct 20233:00 pmRNSTotal Voting Rights
22nd Sep 20237:00 amRNSDato-DXd improved PFS in breast cancer
20th Sep 20237:00 amRNSAlexion completes Pfizer gene therapy agreement
15th Sep 20233:00 pmRNSEnhertu recommended in EU for HER2-mutant NSCLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.